| Lastest Insider Transactions Of Travere Therapeutics, Inc. ( TVTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-05-05 | Sell | 4,500 | 46.65 | 209,925 | 2026-05-06 20:00:35 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-05-05 | Option Exercise | 4,500 | 18.27 | 82,215 | 2026-05-06 20:00:35 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2026-05-04 | Sell | 8,000 | 45.00 | 360,000 | 2026-05-06 20:00:33 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2026-05-04 | Option Exercise | 8,000 | 16.33 | 130,640 | 2026-05-06 20:00:33 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2026-05-04 | Sell | 2,763 | 43.95 | 121,434 | 2026-05-06 20:00:32 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2026-05-04 | Option Exercise | 4,250 | 0.00 | 0 | 2026-05-06 20:00:32 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-05-04 | Sell | 24,250 | 45.06 | 1,092,657 | 2026-05-06 20:00:30 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-05-04 | Option Exercise | 24,250 | 14.81 | 359,200 | 2026-05-06 20:00:30 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-05-04 | Sell | 22,485 | 45.15 | 1,015,086 | 2026-05-06 20:00:28 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-05-04 | Option Exercise | 24,250 | 18.47 | 448,000 | 2026-05-06 20:00:28 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-05-04 | Sell | 2,174 | 46.65 | 101,417 | 2026-05-06 20:00:26 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-05-04 | Option Exercise | 4,250 | 0.00 | 0 | 2026-05-06 20:00:26 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-05-04 | Sell | 22,500 | 43.95 | 988,875 | 2026-05-06 20:00:24 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-05-04 | Option Exercise | 22,500 | 0.00 | 0 | 2026-05-06 20:00:24 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-05-04 | Sell | 2,491 | 46.31 | 115,368 | 2026-05-06 20:00:22 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-05-04 | Option Exercise | 4,250 | 0.00 | 0 | 2026-05-06 20:00:22 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-05-01 | Sell | 9,750 | 44.22 | 431,145 | 2026-05-04 16:27:24 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-05-01 | Option Exercise | 9,750 | 6.82 | 66,495 | 2026-05-04 16:27:24 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2026-04-22 | Sell | 9,100 | 39.09 | 355,719 | 2026-04-23 16:05:06 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2026-04-14 | Sell | 8,000 | 41.07 | 328,560 | 2026-04-16 16:05:17 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2026-04-14 | Option Exercise | 8,000 | 16.33 | 130,640 | 2026-04-16 16:05:17 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-04-14 | Sell | 32,750 | 41.29 | 1,352,130 | 2026-04-16 16:05:15 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-04-14 | Option Exercise | 32,750 | 17.60 | 576,308 | 2026-04-16 16:05:15 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | Sell | 21,977 | 41.07 | 902,595 | 2026-04-16 16:05:10 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | Option Exercise | 15,250 | 16.05 | 244,803 | 2026-04-16 16:05:10 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-04-13 | Sell | 7,215 | 41.93 | 302,516 | 2026-04-15 21:49:26 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-04-13 | Sell | 64,000 | 41.09 | 2,629,975 | 2026-04-15 21:48:12 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-13 | Sell | 51,500 | 41.29 | 2,126,452 | 2026-04-15 21:47:34 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-13 | Option Exercise | 37,500 | 17.76 | 665,950 | 2026-04-15 21:47:34 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-04-13 | Sell | 8,327 | 41.91 | 348,974 | 2026-04-15 21:46:57 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-04-13 | Sell | 8,233 | 42.01 | 345,893 | 2026-04-15 21:46:38 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-04-06 | Sell | 10,000 | 33.00 | 330,000 | 2026-04-07 18:17:22 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2026-04-06 | Option Exercise | 10,000 | 26.52 | 265,200 | 2026-04-07 18:17:22 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-04-01 | Sell | 60,000 | 30.93 | 1,855,839 | 2026-04-02 17:55:15 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-04-01 | Option Exercise | 60,000 | 15.46 | 927,600 | 2026-04-02 17:55:15 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-01 | Sell | 10,000 | 30.00 | 300,000 | 2026-04-02 17:55:13 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-04-01 | Option Exercise | 10,000 | 15.46 | 154,600 | 2026-04-02 17:55:13 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-03-16 | Sell | 10,000 | 28.09 | 280,861 | 2026-03-18 16:05:31 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-03-16 | Option Exercise | 10,000 | 19.08 | 190,800 | 2026-03-18 16:05:31 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-02-20 | Sell | 60,000 | 30.10 | 1,805,766 | 2026-02-24 16:05:14 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-02-20 | Option Exercise | 60,000 | 15.46 | 927,600 | 2026-02-24 16:05:14 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-17 | Sell | 10,000 | 27.83 | 278,315 | 2026-02-19 16:10:04 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-17 | Option Exercise | 10,000 | 19.08 | 190,800 | 2026-02-19 16:10:04 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-02-04 | Sell | 1,779 | 32.21 | 57,295 | 2026-02-05 16:05:25 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-02-04 | Sell | 1,745 | 32.19 | 56,168 | 2026-02-05 16:05:23 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-02-04 | Sell | 2,994 | 32.18 | 96,359 | 2026-02-05 16:05:13 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-01-31 | Sell | 100,087 | 32.28 | 3,230,316 | 2026-02-03 21:30:16 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-01-31 | Sell | 6,956 | 32.12 | 223,427 | 2026-02-03 21:30:14 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2026-01-31 | Sell | 7,242 | 32.12 | 232,613 | 2026-02-03 21:30:12 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2026-01-31 | Sell | 7,310 | 32.12 | 234,797 | 2026-02-03 21:30:10 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2026-01-31 | Sell | 12,446 | 32.87 | 409,100 | 2026-02-03 21:30:08 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2026-01-31 | Sell | 4,333 | 32.12 | 139,176 | 2026-02-03 21:30:07 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-01-31 | Sell | 7,175 | 32.12 | 230,461 | 2026-02-03 21:30:06 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-01-23 | Sell | 60,000 | 30.09 | 1,805,134 | 2026-01-27 20:25:48 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2026-01-23 | Option Exercise | 60,000 | 15.46 | 927,600 | 2026-01-27 20:25:48 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-01-20 | Sell | 10,000 | 27.34 | 273,420 | 2026-01-21 16:05:27 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2026-01-20 | Option Exercise | 10,000 | 19.08 | 190,800 | 2026-01-21 16:05:27 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2026-01-05 | Sell | 2,476 | 39.74 | 98,404 | 2026-01-07 16:05:19 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-12-24 | Sell | 4,980 | 40.00 | 199,200 | 2025-12-29 21:11:39 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-12-24 | Sell | 4,980 | 40.00 | 199,200 | 2025-12-29 21:11:39 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-12-24 | Sell | 60,000 | 40.10 | 2,406,180 | 2025-12-29 21:05:37 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-12-24 | Option Exercise | 60,000 | 20.61 | 1,236,600 | 2025-12-29 21:05:37 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-12-24 | Sell | 15,000 | 42.00 | 630,005 | 2025-12-29 21:01:27 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-12-24 | Option Exercise | 15,000 | 8.93 | 133,950 | 2025-12-29 21:01:27 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-12-24 | Sell | 7,402 | 40.00 | 296,080 | 2025-12-29 20:59:12 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-12-24 | Sell | 7,402 | 40.00 | 296,080 | 2025-12-29 20:59:12 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-12-15 | Sell | 2,910 | 36.00 | 104,760 | 2025-12-16 16:23:09 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-12-01 | Sell | 20,000 | 35.01 | 700,202 | 2025-12-03 16:30:13 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-12-01 | Option Exercise | 20,000 | 16.23 | 324,600 | 2025-12-03 16:30:13 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-11-04 | Sell | 67,115 | 36.00 | 2,416,140 | 2025-11-06 16:05:05 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-11-04 | Option Exercise | 61,250 | 24.02 | 1,471,213 | 2025-11-06 16:05:05 |
| TVTX | Travere Therapeutics, Inc. | Coughlin Timothy | Directior | 2025-10-31 | Sell | 18,000 | 35.03 | 630,601 | 2025-11-04 16:05:13 |
| TVTX | Travere Therapeutics, Inc. | Coughlin Timothy | Directior | 2025-10-31 | Option Exercise | 18,000 | 16.95 | 305,040 | 2025-11-04 16:05:13 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-10-31 | Sell | 5,591 | 35.00 | 195,685 | 2025-11-04 16:05:11 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-10-28 | Sell | 120,000 | 30.32 | 3,638,432 | 2025-10-30 16:45:07 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-10-28 | Option Exercise | 120,000 | 15.46 | 1,855,200 | 2025-10-30 16:45:07 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-10-28 | Sell | 2,662 | 30.00 | 79,860 | 2025-10-30 16:45:05 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-09-22 | Sell | 10,000 | 25.00 | 250,000 | 2025-09-24 16:05:07 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-09-22 | Option Exercise | 10,000 | 19.08 | 190,800 | 2025-09-24 16:05:07 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-09-03 | Sell | 573 | 18.51 | 10,608 | 2025-09-05 16:05:07 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-09-03 | Sell | 573 | 18.51 | 10,608 | 2025-09-05 16:05:07 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-08-27 | Sell | 470 | 17.31 | 8,136 | 2025-08-28 16:05:05 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-07-01 | Sell | 815 | 14.65 | 11,940 | 2025-07-02 17:28:57 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-05-02 | Sell | 1,784 | 21.05 | 37,553 | 2025-05-05 21:54:31 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:54:31 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-05-02 | Sell | 18,924 | 21.05 | 398,350 | 2025-05-05 21:53:47 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-05-02 | Option Exercise | 18,924 | 0.00 | 0 | 2025-05-05 21:53:47 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-05-02 | Sell | 1,771 | 21.05 | 37,280 | 2025-05-05 21:53:07 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:53:07 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-05-02 | Sell | 3,198 | 21.05 | 67,318 | 2025-05-05 21:52:22 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Chief Research Officer | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:52:22 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-05-02 | Sell | 4,920 | 21.05 | 103,566 | 2025-05-05 21:51:34 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Chief Legal Officer and GC | 2025-05-02 | Option Exercise | 4,920 | 0.00 | 0 | 2025-05-05 21:51:34 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-04-11 | Sell | 48 | 13.14 | 631 | 2025-04-14 18:23:30 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-10 | Sell | 5,200 | 23.53 | 122,356 | 2025-02-12 21:30:01 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:30:01 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-10 | Sell | 8,000 | 23.53 | 188,240 | 2025-02-12 21:28:28 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:28:28 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Sell | 54,244 | 25.00 | 1,356,100 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Option Exercise | 45,000 | 16.63 | 748,200 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Sell | 54,244 | 25.00 | 1,356,100 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-02-11 | Option Exercise | 45,000 | 16.63 | 748,200 | 2025-02-12 21:27:02 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-10 | Sell | 5,642 | 24.33 | 137,276 | 2025-02-12 21:25:32 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:25:32 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-02-11 | Sell | 11,375 | 24.04 | 273,455 | 2025-02-12 21:23:43 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-10 | Sell | 2,568 | 23.53 | 60,426 | 2025-02-12 21:22:15 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-02-10 | Option Exercise | 8,000 | 0.00 | 0 | 2025-02-12 21:22:15 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-02-06 | Sell | 10,000 | 22.00 | 220,000 | 2025-02-10 18:04:17 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-02-06 | Option Exercise | 10,000 | 17.44 | 174,400 | 2025-02-10 18:04:17 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-01-31 | Sell | 8,951 | 19.78 | 177,051 | 2025-02-04 20:30:29 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-01-31 | Sell | 8,951 | 19.78 | 177,051 | 2025-02-04 20:30:25 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-01-31 | Sell | 50,691 | 20.21 | 1,024,343 | 2025-02-04 20:30:21 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-01-31 | Sell | 5,273 | 20.12 | 106,082 | 2025-02-04 20:30:18 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-01-31 | Sell | 5,166 | 20.12 | 103,940 | 2025-02-04 20:30:15 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-01-31 | Sell | 5,192 | 20.12 | 104,463 | 2025-02-04 20:30:11 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-01-31 | Sell | 3,348 | 20.12 | 67,362 | 2025-02-04 20:30:07 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2025-01-22 | Sell | 2,437 | 19.46 | 47,424 | 2025-01-23 20:40:03 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2025-01-22 | Sell | 10,736 | 19.46 | 208,923 | 2025-01-23 20:39:00 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2025-01-22 | Sell | 2,437 | 19.46 | 47,424 | 2025-01-23 20:37:55 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-01-23 | Sell | 16,000 | 20.00 | 320,000 | 2025-01-23 20:36:55 |
| TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Directior | 2025-01-23 | Option Exercise | 16,000 | 17.50 | 280,000 | 2025-01-23 20:36:55 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2025-01-22 | Sell | 1,584 | 18.94 | 30,002 | 2025-01-23 20:35:44 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2025-01-22 | Sell | 865 | 18.94 | 16,384 | 2025-01-23 20:33:26 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2025-01-22 | Sell | 925 | 18.94 | 17,520 | 2025-01-23 20:31:02 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2025-01-03 | Sell | 2,506 | 19.04 | 47,715 | 2025-01-06 19:21:02 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-12-26 | Sell | 15,000 | 17.22 | 258,278 | 2024-12-27 19:47:04 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-12-26 | Option Exercise | 15,000 | 12.67 | 190,050 | 2024-12-27 19:47:04 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-11-25 | Sell | 12,090 | 18.30 | 221,258 | 2024-11-25 21:00:49 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-11-25 | Option Exercise | 15,000 | 12.67 | 190,050 | 2024-11-25 21:00:49 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2024-10-04 | Sell | 40,000 | 14.73 | 589,101 | 2024-10-04 19:15:51 |
| TVTX | Travere Therapeutics, Inc. | LYONS GARY A | Directior | 2024-10-04 | Option Exercise | 40,000 | 10.48 | 419,200 | 2024-10-04 19:15:51 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2024-09-30 | Sell | 40,000 | 14.06 | 562,324 | 2024-09-30 20:38:12 |
| TVTX | Travere Therapeutics, Inc. | Meckler Jeffrey A | Directior | 2024-09-30 | Option Exercise | 40,000 | 10.48 | 419,200 | 2024-09-30 20:38:12 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-04-11 | Sell | 54 | 6.74 | 364 | 2024-04-12 16:05:08 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-01-31 | Sell | 19,122 | 8.70 | 166,435 | 2024-02-02 16:06:01 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-01-31 | Sell | 4,764 | 8.71 | 41,495 | 2024-02-02 16:05:41 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-01-31 | Sell | 2,820 | 8.53 | 24,058 | 2024-02-02 16:05:37 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-01-31 | Sell | 4,764 | 8.71 | 41,495 | 2024-02-02 16:05:35 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-01-31 | Sell | 4,195 | 8.53 | 35,789 | 2024-02-02 16:05:34 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | CHIEF MEDICAL OFFICER | 2024-01-31 | Sell | 2,174 | 8.53 | 18,547 | 2024-02-02 16:05:27 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-01-31 | Sell | 3,818 | 8.53 | 32,573 | 2024-02-02 16:05:22 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | 2024-01-23 | Sell | 2,062 | 8.96 | 18,476 | 2024-01-25 16:10:27 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | 2024-01-23 | Sell | 7,873 | 8.96 | 70,542 | 2024-01-25 16:10:21 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | 2024-01-23 | Sell | 853 | 9.07 | 7,735 | 2024-01-25 16:10:17 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | 2024-01-23 | Sell | 2,062 | 8.96 | 18,476 | 2024-01-25 16:10:16 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | 2024-01-23 | Sell | 910 | 9.07 | 8,252 | 2024-01-25 16:10:12 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | 2024-01-23 | Sell | 1,559 | 9.07 | 14,138 | 2024-01-25 16:10:11 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | 2024-01-03 | Sell | 2,509 | 9.43 | 23,648 | 2024-01-05 16:11:49 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-10-03 | Sell | 3,091 | 8.25 | 25,504 | 2023-10-04 16:05:09 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-09-05 | Sell | 457 | 14.71 | 6,723 | 2023-09-05 20:15:39 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-08-31 | Sell | 1,815 | 14.71 | 26,699 | 2023-09-05 20:13:54 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-08-31 | Sell | 1,815 | 14.71 | 26,699 | 2023-09-05 20:12:15 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-08-31 | Sell | 4,455 | 14.71 | 65,533 | 2023-09-05 20:10:08 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-05-10 | Sell | 455 | 16.59 | 7,548 | 2023-05-12 16:14:19 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-05-10 | Sell | 825 | 16.59 | 13,687 | 2023-05-12 16:11:57 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-05-10 | Sell | 825 | 16.59 | 13,687 | 2023-05-12 16:09:22 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-05-10 | Sell | 558 | 16.49 | 9,200 | 2023-05-12 16:06:20 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-04-11 | Sell | 47 | 21.49 | 1,010 | 2023-04-13 16:07:27 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-01-31 | Sell | 2,590 | 22.25 | 57,628 | 2023-02-02 19:11:10 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-01-31 | Sell | 2,590 | 22.25 | 57,628 | 2023-02-02 19:08:39 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-01-31 | Sell | 1,779 | 21.75 | 38,697 | 2023-02-02 19:04:53 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-01-31 | Sell | 1,588 | 21.75 | 34,542 | 2023-02-02 19:02:35 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-31 | Sell | 8,196 | 22.25 | 182,361 | 2023-02-02 18:58:33 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-01-31 | Sell | 2,031 | 21.87 | 44,419 | 2023-02-02 18:53:33 |
| TVTX | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | 2023-01-24 | Sell | 1,097 | 21.86 | 23,976 | 2023-01-26 16:05:49 |
| TVTX | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | 2023-01-24 | Sell | 2,062 | 21.50 | 44,333 | 2023-01-26 16:05:48 |
| TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | 2023-01-24 | Sell | 2,062 | 21.50 | 44,333 | 2023-01-26 16:05:38 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-24 | Sell | 6,442 | 21.50 | 138,503 | 2023-01-26 16:05:36 |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | 2023-01-24 | Sell | 852 | 21.90 | 18,663 | 2023-01-26 16:05:28 |
| TVTX | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | 2023-01-24 | Sell | 1,550 | 21.90 | 33,952 | 2023-01-26 16:05:20 |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | 2023-01-05 | Sell | 5,625 | 20.75 | 116,719 | 2023-01-06 16:05:56 |
| TVTX | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | 2023-01-04 | Sell | 2,493 | 20.75 | 51,730 | 2023-01-06 16:05:16 |
